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GRASP-1: A Neuronal RasGEF Associated
with the AMPA Receptor/GRIP Complex
A variety of studies have observed changes in AMPA
receptor responses after LTP induction (Kauer et al.,
1988; Muller et al., 1988; Davies et al., 1989; Isaac et
Bing Ye, Dezhi Liao, Xiaoqun Zhang, Peisu Zhang,
Hualing Dong, and Richard L. Huganir*
Howard Hughes Medical Institute
al., 1995; Liao et al., 1995; Benke et al., 1998). Moreover,Department of Neuroscience
recently, it has been reported that targeted deletion ofThe Johns Hopkins University School of Medicine
the GluRA/GluR1 gene of the AMPA receptor resultsBaltimore, Maryland 21205
in impaired hippocampal LTP (Zamanillo et al., 1999),
further supporting the required involvement of AMPA
receptors in synaptic plasticity.
Summary AMPA receptors have been proposed to be regulated
by at least two distinct mechanisms during the expres-
The PDZ domain±containing proteins, such as PSD- sion of LTP/LTD. Protein phosphorylation/dephosphor-
95 and GRIP, have been suggested to be involved in ylation of AMPA receptors has long been thought to
the targeting of glutamate receptors, a process that be a critical factor in the expression of LTP and LTD
plays a critical role in the efficiency of synaptic trans- (Raymond et al., 1993a; Roche et al., 1996). Recent stud-
mission and plasticity. To address the molecular ies demonstrating that the phosphorylation state of
mechanisms underlying AMPA receptor synaptic lo- AMPA receptors correlates with the formation of LTP
and LTD in hippocampal slices have provided supportcalization, we have identified several GRIP-associated
for this hypothesis (Barria et al., 1997; Kameyama etproteins (GRASPs) that bind to distinct PDZ domains
al., 1998; Lee et al., 1998). More recently, it has beenwithin GRIP. GRASP-1 is a neuronal rasGEF associ-
proposed that the postsynaptic localization of AMPAated with GRIP and AMPA receptors in vivo. Overex-
receptors may be regulated by synaptic activity (Isaacpression of GRASP-1 in cultured neurons specifically
et al., 1995; Liao et al., 1995). According to this hypothe-reduced the synaptic targeting of AMPA receptors.
sis, the induction of LTP results in the insertion or tar-In addition, the subcellular distribution of both AMPA
geting of AMPA receptors at the postsynaptic plasmareceptors and GRASP-1 was rapidly regulated by the
membrane, whereas LTD-inducing stimuli cause the in-activation of NMDA receptors. These results suggest
ternalization or dispersion of AMPA receptors from thethat GRASP-1 may regulate neuronal ras signaling and
postsynaptic plasma membrane. A recent report hascontribute to the regulation of AMPA receptor distribu-
provided evidence for the synaptic insertion of the GluR1
tion by NMDA receptor activity. subunit of AMPA receptors during LTP induction in hip-
pocampal slices (Shi et al., 1999). Moreover, a decrease
Introduction in the number of AMPA receptor clusters at synapses,
but not NMDA receptor clusters, has recently been ob-
Glutamate receptors are the major excitatory neuro- served during the induction of NMDA receptor±depen-
transmitter receptors in the central nervous system dent LTD in cultured neurons (Carroll et al., 1999).
(CNS) (Seeburg, 1993; Hollmann and Heinemann, 1994). The molecular mechanisms underlying the synaptic
The ionotropic glutamate receptors are composed of targeting and the activity-dependent redistribution of
three distinct groups, namely N-methyl-D-aspartic acid glutamate receptors have been an area of recent inter-
(NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazole pro- est. Several proteins that directly interact with glutamate
pionic acid (AMPA), and kainate receptors. NMDA re- receptors such as PSD-95 and GRIP (glutamate receptor
ceptors are essential for the induction of many forms of interacting protein) have been isolated and proposed to
activity-dependent synaptic plasticity in the adult as be involved in glutamate receptor synaptic targeting
well as in the developing animal, while AMPA receptors (Kornau et al., 1995; Dong et al., 1997). A common fea-
mediate rapid excitatory synaptic transmission. These ture of these two proteins is that they are adaptor pro-
receptors are critical for the induction and maintenance teins containing multiple protein±protein interaction mo-
of long-term potentiation (LTP) and long-term depres- tifs called PDZ domains. PSD-95 contains three PDZ
sion (LTD), two cellular models of learning and memory domains, one SH3 domain and one guanylate kinase
(Collingridge, 1987; Bliss and Collingridge, 1993). Antag- homology domain. These domains interact with various
onists of the NMDA receptor, such as APV and MK801, proteins including NMDA receptors, potassium chan-
completely blocked the induction of LTP and LTD (Coan nels, nitric oxide synthase (NOS), neuroligin, synGAP,
et al., 1987; Dudek and Bear, 1992; Mulkey and Malenka, and GKAP (Kornau et al., 1995; Brenman et al., 1996;
1992). The deletion of the NR1 subunit, an essential Irie et al., 1997; Kim et al., 1997, 1998; Chen et al.,
subunit of the NMDA receptor, in hippocampal CA1 re- 1998). Among these proteins, synGAP is a rasGAP highly
gion results in the abolishment of LTP in this region and enriched at excitatory synapses that has been sug-
impaired spatial learning (Tsien et al., 1996). AMPA-type gested to link NMDA receptors to synaptic ras signaling
glutamate receptors are crucial for the expression of (Chen et al., 1998; Kim et al., 1998). GRIP1and GRIP2/
LTP and LTD. LTP and LTD have been proposed to be ABP are adaptor proteins for the AMPA receptor and
mediated, at least in part, by changes in AMPA receptor contain seven PDZ domains, which presumably link
function (Raymond et al., 1993b; Roche et al., 1994). AMPA receptors to other GRIP-associated proteins.
Overexpression of the C-terminal domain of GluR2 that
interacts with GRIP in neurons disrupts the synaptic* To whom correspondence should be addressed (e-mail: rhuganir@
jhmi.edu). targeting of AMPA receptors, suggesting that GRIP or
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Figure 1. Schematic Structure of GRIP1 and
the Sequence and Domain Structure of
GRASP-1
(A) Schematic structure of GRIP1 showing the
regions used in the yeast two-hybrid screens.
(B) Amino acid sequence of GRASP-1. The
three sequence conserved regions (SCRs) of
the rasGEF domain are shown in bold. The
PDZ-like domain is doubly underlined. The
caspase-3 cleavage site is shaded. The under-
lined region is alternatively spliced.
(C) GRASP-1 has a rasGEF domain, a cas-
pase-3 cleavage site, a region homologous
to ras binding domains (RBDs), and a PDZ-
like domain.
related PDZ domain±containing proteins may be re- together (PDZ 4±6), and 7 alone (PDZ 7). Positive clones
were isolated and confirmed by back-transformationquired for synaptic targeting (Dong et al., 1997). How-
ever, the molecular mechanisms underlying the regula- into yeast. Using PDZ domains 1±3, we obtained three
novel genes, designated GRASP-2, -3, and -4 (Table 1).tion of AMPA receptor function by GRIP remain unclear.
To address the regulation of AMPA receptor localiza- Using PDZ domains 4±6, we obtained seven genes that
fall into three distinct classes of PDZ ligands. The firsttion, we set out to identify proteins in the GRIP/AMPA
receptor complex. We performed yeast two-hybrid class of GRASPs contained type I PDZ domain ligand
motifs (T/SXV) at the C terminus of the interacting pro-screens using different PDZ domains of GRIP1 and iso-
lated multiple cDNAs encoding GRIP-associated pro- teins (Songyang et al., 1997) and included the huntingtin-
associated protein HAP1-A (Li et al., 1995). The secondteins (GRASPs). Here, we characterize the GRIP1-asso-
ciated protein, GRASP-1, which specifically interacts class of proteins contained type II T/SXV motifs (`X`,
where ` is a hydrophobic amino acid) (Songyang et al.,with the seventh PDZ domain of GRIP. GRASP-1 is a
neuron-specific guanine nucleotide exchange factor 1997) and included Numb-like (Zhong et al., 1997), P140
(gene accession number AF040944), G2 (gene acces-(GEF) for the ras family of the small G proteins and is
associated with the GRIP/AMPA receptor complex in sion number U10991, and two novel genes (GRASP-5
and -6). The third class of GRASP, isolated over tenbrain. Overexpression of GRASP-1 dramatically inhibits
AMPA receptor synaptic targeting in cultured neurons. times, was GRIP1 itself, confirming that GRIP1 associ-
ates with itself most likely through a PDZ±PDZ interac-Moreover, we found that the distribution of both
GRASP-1 and AMPA receptors is rapidly regulated by tion (Srivastava et al., 1998; Dong et al., 1999). Finally,
using the last PDZ domain (PDZ 7) of GRIP1 as bait,NMDA receptor activity. These results suggest that
GRASP-1 signaling may be involved in the regulation which is alternatively spliced in GRIP2/ABP gene (Sri-
vastava et al., 1998; Dong et al., 1999), we identified aof neuronal ras signaling and AMPA receptor synaptic
targeting. novel gene designated GRASP-1, which will be the focus
of this paper.
Results
Molecular Cloning of GRASP-1 and Examination
of Its Interaction with GRIP1Isolation of GRASPs
The yeast two-hybrid system was employed to screen The seventh PDZ domain of GRIP1 was used as bait
to screen two rat hippocampal cDNA yeast two-hybridfor molecules that interact with the various PDZ domains
of GRIP1 (Figure 1A). A hippocampal cDNA library was libraries. Approximately 3.1 3 106 clones in a random-
primed library and 3.0 3 106 clones in an oligo-dT-independently screened with constructs containing the
PDZ domains 1, 2, and 3 together (PDZ 1±3), 4, 5, and 6 primed library were screened. Eight and twenty-four
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Table 1. GRIP-Associated Proteins Identified through Yeast Two-Hybrid Screening
Bait Prey Homology Remark
PDZ 1, 2, 3 (bait 1) GRASP-3 T/SXV* Novel, SNARE Vesicle transport
GRASP-2 Novel, NAB domain
GRASP-4 Novel, BTB domain
PDZ 4, 5, 6 (bait 2) HAP1-A T/SXV* Huntington's disease
Numblike `X`* Cortical neurogenesis
P140 `X`* Enriched in postnatal nervous system
G2 `X`*
GRASP-5 `X`* Novel, Rap2 interacting protein
GRASP-6 `X`*
GRIP PDZ
PDZ 7 (bait 3) GRASP-1 PDZ Novel, neuronal rasGEF
The PDZ domains 1±3, 4±6, and 7 were used as baits to screen a random-primed rat hippocampal cDNA library. Positive clones were selected
on selective media and assayed for b-galactosidase activity. The clones containing either T/SXV* motifs or PDZ domains are indicated in the
table. The homology to known genes is listed for novel genes.
Asterisks indicate stop codons.
positives, respectively, were isolated from the two librar- Myc-GRASP-1 only, or an empty vector were used as
ies, and all of them encoded the same gene, designated negative controls. Since QT-6 cells do not express en-
GRASP-1. To obtain the full-length gene encoding dogenous AMPA receptor, this result also suggested
GRASP-1, a CapFinder rat hippocampal cDNA library that the interaction between GRASP-1 and GRIP1 does
and an oligo-dT-primed rat hippocampal cDNA l ZAP not require AMPA receptors. GRASP-1 was also found
library were screened with the SalI/SacI fragment (about to associate with GRIP2 using similar coimmunoprecipi-
300 bp) of yeast clone D7-D-12 (the last 1.4 kb of the tation experiments from transfected HEK293 cells (Fig-
whole cDNA) as a probe. The longest clone obtained ure 2B).
from the dT-primed library was z2.8 kb. More than ten
clones of z3 kb were obtained from the CapFinder li-
brary. The GRASP-1 cDNA encoded an 838 amino acid Generation of GRASP-1 Antibodies
protein (Figure 1B). Two splicing isoforms were ob- To analyze the GRASP-1 protein, we generated an anti-
served. The full-length sequence of GRASP-1 was con- body against a fusion protein containing the C-terminal
firmed by comparing the size of in vitro±translated and PDZ (anti-GP1-PDZ) and an antibody against a peptide
heterologously expressed proteins with the endogenous containing the C-terminal 18 amino acids (anti-GP1-
protein in brain (data not shown). Sequence analysis Pep). Both of these antibodies recognized a major pro-
revealed that GRASP-1 has a rasGEF catalytic domain, tein in brain lysates at 110 kDa and a minor protein
a potential caspase-3 cleavage site, a region weakly around 30 kDa (Figure 2C). Antibody recognition of both
homologous to the ras binding domain (RBD) of ralGDS the 110 kDa and the 30 kDa proteins was blocked when
(Hofer et al., 1994; Spaargaren and Bischoff, 1994), and the antibodies were preincubated with antigen (data not
a PDZ domain (Figure 1C). This overall domain structure shown). The 30 kDa protein is a caspase-3 proteolytic
is similar to ralGDS, which contains an N-terminal GEF product of the full-length protein (see below).
catalytic domain and a C-terminal regulatory domain
(Hofer et al., 1994; Spaargaren and Bischoff, 1994).
Unlike most PDZ domain±interacting proteins, GRASP-1
GRASP-1, GRIP1, and AMPA Receptors Formdoes not contain a characterized type I or II PDZ ligand
a Protein Complex In Vivoat its C terminus (Kornau et al., 1995; Saras and Heldin,
To see if GRIP1 and GRASP-1 are associated in neurons,1996; Songyang et al., 1997). To identify the region of
coimmunoprecipitation experiments were performed withGRASP-1 required for interaction with GRIP1, we ana-
detergent extracts from cultured cortical neurons (Fig-lyzed the interaction of various GRASP-1 constructs
ure 2D). Anti-GRIP1 antibody, but not anti-Myc or anti-with GRIP1 using the yeast two-hybrid system (Figure
SAP102, immunoprecipitated GRASP-1 from cultured2A). These experiments demonstrated that the last 100
neuron lysates, suggesting that GRIP1 and GRASP-1amino acids encoding the PDZ domain were required
interact in neurons. GRIP1 contains seven PDZ domains,and sufficient for the interaction, suggesting that the
which have been proposed to serve as adaptor modulesinteraction between GRASP-1 and GRIP1 is most likely
to link AMPA receptors to other neuronal proteins (Dongmediated through a PDZ±PDZ interaction similar to the
et al., 1997). To explore whether GRASP-1 forms a com-previously described interaction between PSD-95 and
plex with GRIP1 and AMPA receptors in vivo, the interac-NOS (Brenman et al., 1996). To further confirm the
tion of these three proteins in solubilized brain plasmaGRIP1-GRASP-1 association, we analyzed the interac-
membrane extracts was analyzed using coimmunopre-tion of GRIP1 and GRASP-1 in transfected fibroblasts.
cipitation techniques. Isolation of AMPA receptors fromQT-6 cells were cotransfected with a Myc-tagged
brain lysates using a GluR2 monoclonal antibody coim-GRASP-1 construct with a full-length GRIP1 cDNA, and
munoprecipitated GRASP-1, together with GRIP1 (Fig-immunoprecipitations were performed from cell lysates
ure 2D). In contrast, control monoclonal antibodieswith anti-Myc antibody or anti-GRIP1 antibody (Figure
against Myc or the NR1 subunit of NMDA receptors2B). These experiments demonstrated that a GRASP-
did not coimmunoprecipitate either GRASP-1 or GRIP1.1-GRIP1 complex could be isolated from the cotrans-
These results indicate that GRASP-1 specifically formsfected cells using either the anti-GRIP1 or anti-Myc anti-
bodies. Lysates from cells transfected with GRIP1 only, a complex with GRIP1 and AMPA receptors in the brain.
Neuron
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Figure 2. Association of GRASP-1 and GRIP1
In Vitro and In Vivo
(A) Mapping of the region in GRASP-1 that
interacts with GRIP1 using the yeast two-
hybrid system. Wild-type and deletion con-
structs of the C-terminal domain downstream
of the caspase cleavage site were trans-
formed into yeast HF7C together with GRIP1
PDZ 7 and assayed for growth on media defi-
cient of leucine, tryptophan, and histidine.
(B) Coimmunoprecipitation of GRIP1 and
GRASP-1 from transfected heterologous
cells. For coimmunoprecipitation of GRIP1
and GRASP-1, QT-6 cells were cotransfected
with Myc-tagged GRASP-1 and a full-length
GRIP1 construct (lanes 4 and 8), with Myc-
GRASP-1 alone (lanes 3 and 7), or with GRIP1
alone (lanes 2 and 6) or were mock trans-
fected (lanes 1 and 5). The cell lysates were
immunoprecipitated with either anti-Myc an-
tibody (lanes 1±4) or anti-GRIP1 antibody
(lanes 5±8). The immunoprecipitates were an-
alyzed by Western analysis with either anti-
GRIP1 antibody (lanes 1±4) or anti-Myc-anti-
body (lanes 5±8). For coimmunoprecipitation
of GRIP2 and GRASP-1, HEK293T cells were
cotransfected with HA-tagged GRIP2 PDZ 7
and Myc-GRASP-1 or these two constructs
separately. Anti-Myc antibody was used for
immunoprecipitation and anti-HA antibody
was used for Western analysis.
(C) Western analysis on brain lysates with two
anti-GRASP-1 antibodies, anti-GP1-PDZ, and
anti-GP1-Pep.
(D) Coimmunoprecipitation of GRASP-1 and
GRIP1 from solubilized cortical cultures. Rab-
bit polyclonal antibodies against Myc and
SAP102 as controls or GRIP1 were incubated
with 2% Triton X-100-solubilized high-den-
sity cortical cultured neurons and protein
A-Sepharose. After washes, the immunoprecipitates were eluted with Laemmli sample buffer, separated by 7.5% SDS±PAGE, and transferred
to PVDF membrane. The PVDF membrane was then probed with anti-GP1-Pep to detect GRASP-1.
(E) Coimmunoprecipitation of GRASP-1, GRIP1, and AMPA receptors from rat brain total membrane fraction. Mouse monoclonal antibodies
against GluR2, NR1, or Myc were incubated with deoxycholate-solubilized rat brain membrane extracts and protein G-Sepharose, and the
isolated immunoprecipitates were separated by 7.5% SDS±PAGE and transferred to PVDF membrane. The PVDF membranes were then
probed with anti-GRASP-1 (anti-GP1-PDZ) or anti-GRIP1 antibodies (anti-GRIP1C).
RasGEF Activity of GRASP-1 GRASP-1 Is a Substrate of Caspase-3
Both anti-GRASP-1 antibodies against the C-terminalBy analyzing the amino acid sequence with BLAST
search and MACAW program (Schuler et al., 1991), we portion of GRASP-1 recognize a predominant band at
110 kDa and an additional band at about 30 kDa (Figurefound that GRASP-1 contained regions homologous to
the catalytic domain of guanine nucleotide exchange 2C). Sequence analysis of GRASP-1 revealed a putative
cleavage site for caspase-3 (D591TVD594) (Figure 4A) thatfactors (GEFs) for the ras family of small G proteins
(Figure 3A). The rasGEF catalytic domains share homol- would produce a C-terminal proteolytic fragment of
about 30 kDa, close to the size of the 30 kDa proteinogy in three structurally conserved regions (SCRs) sepa-
rated by variable regions (Boguski and McCormick, recognized by the GRASP-1 antibodies. To examine
whether caspase-3 could cleave this site, purified cas-1993; Boriack-Sjodin et al., 1998), and GRASP-1 con-
tains all three SCRs (Figure 3A). To examine whether pase-3 was incubated with in vitro±translated 35S-methi-
onine-labeled GRASP-1. Caspase-3 was found to rap-GRASP-1 has rasGEF activity, we generated a bacteri-
ally expressed GST fusion protein (GST-C) containing idly generate a GRASP-1 cleavage product of about
30 kDa (Figure 4B). To confirm the site of caspase-3the GEF catalytic domain upstream of the caspase
cleavage site. The release of GDP from ras was then cleavage, the aspartate residues (D591 and D594) within
this sequence that have been shown to be required formeasured in the presence or absence of this fusion
protein (Albright et al., 1993). H-ras was loaded with caspase-3 cleavage in other proteins were mutated to
glutamates (E) to eliminate cleavage. The resulting mu-[3H]GDP and then incubated with either GST or GST-C.
After incubating with GST-C, H-ras loaded with [3H]GDP tant GRASP-1 (D/E mutant) was not cleaved in vitro by
caspase-3, confirming this as the site of cleavage (Figurerapidly released 80% of its radioactivity within 1 min,
while [3H]GDP-loaded H-ras incubated with GST was 4C). To examine whether the 30 kDa protein observed
in Western blots of brain lysates was in fact the cleavagestable for at least 20 min (Figure 3B). This result confirms
that GRASP-1 has rasGEF activity. product of the 110 kDa full-length protein, we incubated
GRASP-1: A GRIP-Associated Neuronal RasGEF
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Figure 3. The RasGEF Activity of GRASP-1
(A) Alignment of GRASP-1 rasGEF domain
with the rasGEF domains of human SOS1,
cdc25, ralGNRP, and Rlf by ClustalW pro-
gram. The identical amino acids are shown
in black boxes and the similar residues are
shown in gray boxes.
(B) Purified GRASP-1 catalytic domain (GST-
C) promotes dissociation of GDP from ras.
GST-H-ras was loaded with [3H]GDP and then
incubated with either purified GST (open
squares) or GST-C (open triangles). Aliquots
of these two reactions were taken out at dif-
ferent time points and were filtered on HA
filters. The [3H]GDP that remained on H-ras
was measured by liquid scintillation counting.
Note that after incubating with GST-C, H-ras
loaded with [3H]GDP quickly lost 80% of its
radioactivity within 1 min, while H-ras incu-
bated with GST retained its original radioac-
tivity for at least 20 min.
brain lysate with purified caspase-3. With increasing soma and dendritic processes. GRASP-1 was not ob-
served in glia. Consistent with results from Westernincubation times, the amount of the full-length 110 kDa
analysis, GRASP-1 was widely localized in various brainprotein decreased, while the 30 kDa protein increased
regions including cortex, hippocampus, thalamus, stria-(Figure 4D). These results demonstrate that the native
tum, and brainstem cerebellum (Figure 5C). In both cor-30 kDa protein in brain comigrates with the product
tex and hippocampus, the most prominent staining wasfrom in vitro caspase-3 cleavage and suggests that this
observed in pyramidal cells, although other neuronsprotein is likely to be an in vivo caspase-3 cleavage
were also stained. In cerebellum, Purkinje cells andproduct of GRASP-1. Interestingly, this cleavage results
granule cells were positive for GRASP-1 immunoreactiv-in the separation of the N-terminal catalytic domain from
ity. The cellular distribution of GRASP-1 is similar to thatthe potential C-terminal regulatory domain.
of GRIP1 and AMPA receptors (Petralia et al., 1994,
1997; Wyszynski et al., 1998; Dong et al., 1999).
Neuronal Expression of GRASP-1
To examine the tissue distribution of GRASP-1, Western GRASP-1 Is Distributed to Punctate Structures in
analysis was performed on cell lysates from multiple Neurons and Is Partially Localized to Synapses
tissues using the anti-GP1-PDZ fusion protein antibody GRIP1 partially colocalizes with AMPA receptors at ex-
(Figures 5A and 5B). GRASP-1 (110 kDa) was specifically citatory synapses and is enriched in postsynaptic den-
expressed in all tissues of the nervous system including sity (PSD) fraction of brain homogenate (Dong et al.,
cortex, cerebellum, hippocampus, olfactory bulb, thala- 1997, 1999; Wyszynski et al., 1998). To determine the
mus, spinal cord, and brainstem and was not detected subcellular distribution of GRASP-1 in neurons, embry-
in muscle, lung, heart, liver, kidney, and spleen (Figures onic hippocampal neuronal cultures (embryonic day 18,
5A and 5B). Northern analysis showed a similar tissue 3 weeks in vitro) were stained with Fluo-EX-labeled
distribution and identified a 3.0±3.5 kb GRASP-1 mRNA anti-GP1-PDZ antibody, and then analyzed using immu-
(data not shown). The distribution of GRASP-1 is similar nocytofluorescence techniques (Figure 6Aa). GRASP-1
to that of GRIP1 and -2, which has previously been was distributed throughout the cell soma (Figure 6Ab)
shown to be specifically expressed in neurons (Dong et and dendrites (Figure 6Ac) as small fluorescent puncta.
al., 1997). The specificity of the staining was confirmed by both
To further investigate the cellular distribution of blocking with the antigen (data not shown) and the high
GRASP-1, immunohistochemistry was performed with degree of colocalization of the punctate staining by anti-
the GP1-PDZ fusion protein antibody (Figure 5C). GP1-PDZ and anti-GP1-Pep, two different antibodies
against GRASP-1 (Figures 6Ba and 6Bb).GRASP-1 was specifically expressed in neurons in the
Neuron
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Figure 4. GRASP-1 Is a Substrate for Cas-
pase-3 In Vivo and In Vitro
(A) Comparison of the amino acid sequence
of the putative caspase-3 cleavage site in
GRASP-1 (D591TVD594) with other identified cas-
pase-3 cleavage sites. The identical amino
acids between the sites of GRASP-1 and
MEKK1 are shown in bold.
(B) Cleavage of in vitro±translated 35S-methio-
nine-labeled GRASP-1 by purified caspase-3.
Left lane, cleavage reaction without purified
caspase-3. Right lane, cleavage reaction with
purified caspase-3.
(C) Caspase-3 cleaves at D591 and D594. The
putative caspase-3 cleavage site was mu-
tated in GRASP-1 (D/E mutant) and translated
in vitro and used as substrate for in vitro cas-
pase-3 cleavage reactions followed by West-
ern analysis using anti-GR1-PDZ antibody.
The wild-type protein was cleaved (left lane),
whereas the D/E mutant was not (right lane).
(D) The in vitro cleavage product comigrates
with the 30 kDa band recognized by GRASP-1
antibodies. Brain lysates (2 mg) were incu-
bated in the presence or absence of purified
caspase-3 (200 ng) for variable times. Note
that with increasing incubation times, the ra-
tio of the 30 kDa band over the full-length
110 kDa protein increased in the presence
of caspase-3, while the ratio was relatively
stable in the absence of caspase-3.
To examine whether GRASP-1 was distributed to syn- been implicated in the synaptic localization of AMPA
receptors. To explore the possibility that GRASP-1 regu-apses, the cultured neurons were triple-labeled with an-
tibodies against GRASP-1, GRIP1, and synaptophysin, lates AMPA receptor distribution, we overexpressed a
Myc-tagged full-length GRASP-1 in primary neuronala marker for synapses. A subset of the GRASP-1 puncta
colocalized with GRIP1 and synaptophysin, suggesting cultures. Low-density hippocampal neurons were trans-
fected at 3±5 days in vitro with constructs containingGRASP-1 and GRIP1 can be colocalized at synapses
(Figure 6C). To further investigate the subcellular distri- either Myc-GRASP-1 or GFP. The transfected coverslips
were cultured for another 9±11 days and then labeledbution of GRASP-1, we performed biochemical subcel-
lular fractionation of rat brain lysate. GRASP-1 (110 kDa) with a polyclonal antibody against GluR1 or NR1 (Liao
et al., 1999). The neurons that were transfected withwas distributed in every fraction examined with a mod-
est enrichment in the PSD1 fraction as well as in the Myc-GRASP-1 were identified by double labeling the
neurons with a Myc staining, while the neurons trans-cytosol (S2) (Figure 5D). Neither 0.5% Triton X-100 nor
3% sarcosyl solubilized the GRASP-1 in the PSD frac- fected with GFP were detected with GFP fluorescence.
Strikingly, we observed that overexpression of Myc-tion. Interestingly, the 30 kDa GRASP-1 caspase-3
cleavage product was enriched in cytosolic fractions GRASP-1 in neurons dramatically reduced the number
of synaptic AMPA receptor clusters (Figures 7A and 7C)(S2 and SC) but not the PSD fraction and was readily
solubilized by 3% sarcosyl (Figure 5D). The distribution compared to cells overexpressing GFP or untransfected
cells on the same coverslip (Figures 7B and 7C). In con-of GRASP-1 is distinct from soluble protein lactate dehy-
drogenase (LDH) and the synaptic GluR2/3 subunit (Fig- trast, overexpression of GRASP-1 had no significant
effect on the number of NMDA receptor clusters (Figuresure 5D). The partial distribution of GRASP-1 between
cytosol and membrane is in agreement with the finding 7A±7C). Consistent with previous findings, approxi-
that many rasGEFs are partially localized to the mem- mately half of the synaptic AMPA clusters colocalized
brane fraction, reflecting their dynamically regulated with NMDA clusters in untransfected cells (Figure 7C)
membrane association (Quilliam et al., 1994, 1995). (Liao et al., 1999). This result suggests that the overex-
pression of GRASP-1 specifically disrupts AMPA recep-
tor synaptic targeting.Overexpression of GRASP-1 Decreases the Synaptic
To study the domain requirement for disruption ofLocalization of AMPA Receptors
AMPA receptor targeting, we generated specific dele-The results presented so far show that GRASP-1 is a
tion mutants of GRASP-1. To inactivate the GEF domain,novel neuronal rasGEF that interacts with GRIP and ex-
we deleted the second SCR (DSCR; D amino acids 150±ists in a protein complex with GRIP1 and AMPA recep-
192) in the catalytic domain. Deletion of this region elimi-tors in vivo. Together with other AMPA receptor±
interacting proteins such as Pick-1 and NSF, GRIP1 has nated the disruption of the synaptic targeting of the
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Figure 5. Neuronal Expression of GRASP-1
(A and B) Western analysis of GRASP-1 distri-
bution. GRASP-1 was specifically expressed
in brain tissues represented by cortex and
hippocampus and was absent in muscle,
lung, heart, liver, kidney, and spleen (A).
GRASP-1 was expressed in various regions
in brain including cortex, cerebellum, hippo-
campus, olfactory bulb, spinal cord, and
brainstem (B).
(C) Immunohistochemistry of GRASP-1 in dif-
ferent brain regions.
(D) Western analysis of the localization of
GRASP-1 in subcellular fractions of rat brain
homogenate. Ten micrograms of protein from
each fraction were separated on a SDS-poly-
acrylamide gel. The same PVDF membrane
was probed with anti-GRASP-1 (anti-GP1-
PDZ), anti-LDH (1:1000, Chemicon), and anti-
GluR2/3 (JH1684, 1:500) sequentially after
stripping.
AMPA receptors by GRASP-1 overexpression (Figures GluR1 or GRASP-1 together with NR1. Consistent with
a previous study (Lissin et al., 1999), we observed that8A and 8B). In addition, deletion of the C-terminal ªregu-
latoryº domain (DR; D amino acids 592±827) eliminated glutamate treatment caused a pronounced reduction of
the synaptic AMPA receptor clusters (Figures 9Aa andthe effect of GRASP-1 overexpression on AMPA recep-
tor targeting (Figures 8A and 8B). These results suggest 9Ad) while exhibiting no significant effects on NMDA
receptor localization (Figures 9Ab and 9Ae). The effectthat the rasGEF activity is required but not sufficient
for disruption of AMPA receptor synaptic targeting and of glutamate did not appear to be due to excitotoxicity,
as the synaptic targeting of AMPA receptors recoveredindicate that the C-terminal ªregulatoryº domain may be
required for the proper regulation or localization of the after several hours in normal media (data not shown).
The glutamate-induced redistribution of AMPA recep-GEF activity.
tors was NMDA receptor±dependent since the NMDA
receptor antagonist APV (200 mM) completely blockedNMDA Receptor±Induced AMPA Receptor
the effects of glutamate, while the AMPA receptor antag-and GRASP-1 Redistribution
onist CNQX (20 mM) had no effect (data not shown).Recent studies have indicated that the redistribution of
Intriguingly, glutamate-treatment also caused a verysynaptic AMPA receptors may be critical for the expres-
dramatic dispersal of the GRASP-1 immunoreactivesion of LTP and LTD (Davies et al., 1989; Isaac et al.,
puncti in the soma and dendritic processes (Figures 9Ba1995; Liao et al., 1995; Malenka and Nicoll, 1997). Experi-
and 9Bb). The disappearance of GRASP-1 immunoreac-ments in cultured neurons have recently shown that
tive puncti was not due to degradation or cleavage oflow-frequency stimulation or glutamate treatment rap-
GRASP-1, since the amount of GRASP-1 protein in theidly depresses AMPA receptor responses and de-
cultures was stable for at least 1 hr after the transientcreases the number of AMPA receptor synaptic clusters
glutamate treatment (Figure 9C). As with the redistribu-(Carroll et al., 1999; Lissin et al., 1999). To address
tion of the AMPA receptors, the glutamate-induced re-whether GRASP-1 may be involved in this process, we
distribution of GRASP-1 was blocked by APV, while CNQXactivated glutamate receptors in high-density cultured
had no effect (Figures 9Bc and 9Bd). These results,cortical neurons (embryonic day 17, 3 weeks in vitro)
with 40 mM glutamate for 5 min and then stained for combined with the GRASP-1 overexpression data pre-
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Figure 6. GRASP-1 Is Partially Localized to
Synapses
(A) Immunocytochemistry of GRASP-1.
(a) Low-density hippocampal cultured neu-
rons were immunostained with Cy3-labeled
anti-GRASP-1 antibody (anti-GP1-PDZ).
(b) Close-up of a region of the soma.
(c) Close-up of the dendrites.
(B) Two different anti-GRASP-1 antibodies
stained the same structure.
(a) Staining with Cy3-labeled anti-GP1-PDZ.
(b) Staining with the Cy2-labeled anti-GP1-
Pep.
(Insets) Close-up of the boxed regions.
(C) Colocalization of GRASP-1, GRIP1, and
synaptophysin. Low-density hippocampal
neurons were triply stained with Cy3-labled
anti-GRASP-1 (a), Cy2-labled anti-GRIP1 (b),
and mouse monoclonal anti-synaptophysin
antibodies (c). Arrows show colocalized
GRASP-1, GRIP1, and synaptophysin.
sented above, suggest that GRASP-1 may be important differentiation, and transformation. However, recent
studies have shown that ras signaling is critical forin the regulation of AMPA receptor synaptic targeting.
NMDA-dependent synaptic plasticity in the brain. NMDA
receptor activation leads to the activation of ras and theDiscussion
MAPK kinase pathway (Yun et al., 1998). Moreover, using
genetically engineered mice several laboratories haveGRIP1 and -2 are multi±PDZ domain±containing pro-
suggested that distinct ras signaling molecules may beteins that appear to serve as adaptor proteins to link
critical for synaptic plasticity in several different brainAMPA receptors to other neuronal proteins through the
regions (Orban et al., 1999). Mice deficient in rasGRF,interaction of its PDZ domains with specific protein li-
a neuronal GEF for ras, exhibit impaired amygdala LTPgands. In this study we describe the isolation of several
and impaired fear conditioning, a form of amygdala-proteins that specifically interact with distinct PDZ do-
dependent learning (Brambilla et al., 1997). In contrast,mains in GRIP. We characterize one of these proteins
hippocampal CA1 LTP and spatial learning appearedin detail and report that GRASP-1 is a novel protein that
normal in these mice, suggesting that rasGRF is specifi-interacts with PDZ 7 of GRIP1 and -2 and is associated
cally involved in synaptic plasticity in the amygdala.with AMPA receptors and GRIP1 in vivo in rat brain.
However, heterozygous mice with targeted deletions inGRASP-1 is a neuronal specific rasGEF that is a member
the NF1 gene, a rasGAP gene, have been shown to haveof a novel rasGEF family. GRASP-1 has a complex do-
defects in spatial learning (Silva et al., 1997), suggestingmain structure that has some similarities to the ralGDS
that hippocampal synaptic plasticity also requires thefamily of rasGEFs (Albright et al., 1993; Hofer et al., 1994;
regulation of ras signaling. The ras subfamily includesKikuchi et al., 1994) and includes a rasGEF domain in
several members including ras, rap, ral, rin/rit, and rhebthe N-terminal region and RBD and PDZ domains in the
proteins that vary in their biochemical properties andC-terminal region. GEFs positively regulate the activa-
cellular and tissue distributions, suggesting that theytion of the ras, rho, rab, ran, and ARF families of small
each have distinct physiological roles. For example, rinG proteins (Bourne et al., 1991; Boguski and McCormick,
and rheb are enriched in neurons (Yamagata et al., 1994;1993; Quilliam et al., 1995).
Lee et al., 1996; Wes et al., 1996), while ras, rap, ral,Ras was the first identified small G protein and is
involved in a variety of functions including cell growth, and rit are expressed ubiquitously. Rin and rit can bind to
GRASP-1: A GRIP-Associated Neuronal RasGEF
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Figure 7. Overexpression of GRASP-1 Spe-
cifically Reduces AMPA Receptor Clusters
Low-density hippocampal neurons cultured
on coverslips were transfected with either
Myc-GRASP-1 or pEGFP. After 9±11 days,
the neurons were immunostained to examine
NMDA and AMPA receptor distribution.
(A) GluR1 and NR1 staining in neurons over-
expressing Myc-GRASP-1.
(B) GluR1 and NR1 staining in neurons over-
expressing GFP.
(C) Statistical analysis of the transfection ex-
periments. Data represent the mean 6 SD of
the number of cells indicated by n; *p , 0.01
compared with GFP-transfected cells using t
test.
calmodulin, suggesting that they might link membrane 1994, 1995). For example, the rasGEF SOS1 is recruited
to signal transduction complexes containing receptorcalcium channels, including NMDA receptors, to ras-
like signaling pathways (Lee et al., 1996; Wes et al., tyrosine kinases by the adaptor molecule Grb2. The as-
sociation of SOS1 with the receptor brings it to plasma1996), while rheb is an immediate-early gene that ap-
pears to be involved in neuronal plasticity (Yamagata et membrane where it is able to activate ras (Buday and
Downward, 1993; Chardin et al., 1993; Li et al., 1993;al., 1994; Yee and Worley, 1997). Although GRASP-1
can serve as a rasGEF in vitro, it is still not clear which Olivier et al., 1993; Rozakis-Adcock et al., 1993). GRIP1
has seven PDZ domains, which mediate protein±proteinras is the in vivo target of GRASP-1.
The functional roles of the other identified domains interactions, allowing the recruitment of GRASP-1 to a
large signal-transducing complex (Dong et al., 1997).of GRASP-1 are not clear, although they most likely play
a role in the regulation of the GEF activity of GRASP-1. Previous studies have shown that GRIP1 interacts with
the GluR2 subunit of AMPA receptors and with the EphRBD domains have previously been observed in combi-
nation with GEF domains in the ralGDS family of GEFs. receptor tyrosine kinases and their ligands, such as
ephrin-B2 (Torres et al., 1998; Bruckner et al., 1999). TheIn ralGDS, the binding of ras to the RBD activates its
GEF activity toward its target small G protein ral (Hofer association with ephrin-B2 results in the recruitment of
GRIP to raft membrane microdomains, a highly orga-et al., 1994; Spaargaren and Bischoff, 1994; Urano et
al., 1996). It is likely that binding of ras-like proteins to nized membrane region that has been proposed to be
important for various signal transduction pathways.the RBD region of GRASP-1 may also regulate its GEF
activity. Our results demonstrate that the PDZ domain Moreover, stimulation of ephrin-B resulted in the recruit-
ment of GRIP to large raft patches on the cell surface,of GRASP-1 binds to the seventh PDZ domain of GRIP,
suggesting that GRIP may serve as an adaptor protein presumably bringing a signaling complex into close prox-
imity to ephrin-B. These results suggest that GRASP-1to link GRASP-1 with other GRIP-associated proteins.
Previous studies in other systems have shown that the in addition to regulating AMPA receptor function may
also be important in Eph and ephrin signaling.recruitment of rasGEFs to signal transduction com-
plexes plays a critical role in the activation of G proteins Recent structural analysis of the PDZ±PDZ interaction
of nNOS and syntrophin revealed that the interaction isand downstream signal transduction (Quilliam et al.,
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Figure 8. GEF and Regulatory Domains of
GRASP-1 Required to Disrupt Synaptic Tar-
geting
Low-density hippocampal neurons cultured
on coverslips were transfected with the indi-
cated DNA plasmids at 3±5 days in vitro and
were immunostained after 14 days.
(A) GluR1 staining in neurons overexpressing
GFP (a), Myc-GRASP-1 (b), Myc-GRASP-
1DSCR2 (c), and Myc-GRASP-1-DR (d).
(B) Statistical analysis of the transfection ex-
periments. The level of expression of the vari-
ous deletion mutants was similar as detected
by staining with anti-Myc antibody (not
shown). Data represent the mean 6 SEM of
the number of cells indicated by n; *p , 0.01
analyzed by ANOVA.
mediated by a b finger flanking the nNOS PDZ domain of a caspase inhibitor (zVAD-fmk) to adult rats impairs
learning ability in the Morris water maze (Chan and Matt-which mimics a COOH-terminal T/SXV PDZ ligand motif.
Analysis of the secondary structure of GRIP1 and -2 by son, 1999). These data suggest that caspase-3 may play
nonapoptotic roles in neuronal function. Although theChou-Fasman and Robson-Garnier methods suggests
that a similar b sheet±b turn±b sheet structure may be consequence of caspase cleavage of GRASP-1 is un-
clear, it is possible that it may uncouple the C-terminalconserved in the seventh PDZ of GRIP1 and -2. This
structure has a pseudo-T/SXV motif (DLVI) in the first b ªregulatoryº domain of GRASP-1 from the rasGEF do-
main, disrupting the proper regulation or targeting ofsheet that may be important for the PDZ±PDZ inter-
action. GEF. In fact, overexpression of the N-terminal GEF cata-
lytic domain (DR) was not sufficient to downregulateInterestingly the rasGEF domain of GRASP-1 is sepa-
rated from the RBD and PDZ domains by a functional AMPA receptor synaptic targeting. This idea is consis-
tent with the effect of caspase-3 on MEKK1. Caspase-3caspase-3 cleavage site. Caspase-3 is a critical prote-
ase in the protease cascade central to programmed cleavage of MEK kinase 1 (MEKK1) results in its constitu-
tive activation and redistribution of MEKK1 kinase do-cell death (reviewed by Thornberry and Lazebnik, 1998).
Caspase-3 cleavage of substrate proteins regulates main from membranes to cytosolic fractions (Widmann
et al., 1998).their function and results in the inactivation of apoptosis
inhibitors (Bcl-2 and ICAD), the disassembly of cell struc- LTP and LTD have been proposed to be mediated, in
part, by changes in AMPA receptor function. Increasestures (lamins), and the deregulation of enzymes through
the separation of regulatory and catalytic domains (gel- in AMPA receptor responses have been observed during
the expression of LTP (Kauer et al., 1988; Muller et al.,solin, DNA-PKcs, and MEKK1) (reviewed by Thornberry
and Lazebnik, 1998). Recently, it has been shown that 1988; Davies et al., 1989; Liao et al., 1995). Recently, it
has been shown that a high proportion of synapses incaspase-3 activation occurs after nontoxic depolariza-
tion (30 mM and 100 mM K1) of cultured hippocampal hippocampal CA1 region contains only NMDA receptors
and acquires AMPA receptors only after the inductionneurons, and, moreover, intraventricular administration
GRASP-1: A GRIP-Associated Neuronal RasGEF
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Figure 9. Glutamate Induces Redistribution
of GRASP-1 and AMPA Receptors
(A) Glutamate (40 mM) treatment caused a
dramatic loss of AMPA receptor clusters
compared to cortical cells (a and d) but had
no effect on NMDA receptor localization (b
and e). (c) and (f) show overlap of the NMDA
receptor staining (b or e) and the AMPA re-
ceptor staining (a or d). The AMPA receptor
(GluR1/2/3) staining is indicated in red. The
NMDA receptor (NR1) staining is indicated in
green, and the overlapping regions are indi-
cated in yellow. High-density cortical neu-
ronal cultures on coverslips were stained with
anti-NR1 (NMDA receptors) or anti-GluR1
plus anti-GluR2/3 (AMPA receptors) anti-
bodies.
(B) Glutamate induced redistribution of
GRASP-1 (a and b). Note that the bright
puncta of GRASP-1 immunofluorescence in
the soma and processes disappeared and
became more diffuse after the glutamate
treatment. Two hundred micromolar APV (c)
but not twenty micromolar CNQX (d) blocked
the effect of glutamate on GRASP-1 distri-
bution.
(C) Western analysis of the GRASP-1 protein
amount at different time points after the tran-
sient glutamate treatment. The same type of
cultured neurons was used except that the
neurons were plated on coated dishes rather
than coverslips.
of LTP (Isaac et al., 1995; Liao et al., 1995). This emer- and possibly ras signaling may play a role in the regula-
gence of AMPA receptor current seems due to the ap- tion of AMPA receptor synaptic targeting and its regula-
pearance of synaptic AMPA receptors (Liao et al., 1999; tion by NMDA receptor activity.
Shi et al., 1999). Moreover, NMDA receptor±dependent
Experimental ProceduresLTD in cultured neurons has recently been observed to
correlate with a decrease in the levels of synaptic AMPA
Yeast Two-Hybrid Screening and Full-Length cDNA Cloningreceptors (Carroll et al., 1999). Previous studies have
The PDZ domains 1, 2, and 3 together, 4, 5, and 6 together, and 7suggested that AMPA receptor±associated proteins,
alone were subcloned into yeast expression vector pPC97 in a fusionsuch as GRIP, are involved in the synaptic targeting of
with the GAL4 DNA binding domain. These constructs were trans-AMPA receptors (Song et al., 1998; Xia et al., 1999). In formed into yeast strain Y190 by the lithium acetate method (Straus
this study, we have added GRASP-1 to this complex and Ausubel, 1990). Transformants were selected on leucine-defi-
and provided evidence that it may also be important in cient (Leu2) medium and subsequently transformed with a rat hippo-
regulation of AMPA receptor function and play a role in campal cDNA library subcloned into vector pPC86. For screening
AMPA receptor synaptic targeting. Overexpression of with bait 1 (PDZ 1, 2, 3) and bait 2 (PDZ 4, 5, 6), random-primed rat
hippocampal library was used. For screening with bait 3 (PDZ 7),GRASP-1 in neurons downregulated synaptic AMPA re-
both random-primed and oligo-dT-primed libraries were used (giftsceptor clusters, while it had no effect on synaptic NMDA
of Dr. Anthony Lanahan and Dr. Paul Worley). Positive clones werereceptor synaptic targeting. Both the rasGEF catalytic
selected on triple-deficient plates (Leu2, Trp2, His2) containing 50domain and the C-terminal ªregulatoryº domain were
mM 3-aminotriazole and assayed for b-galactosidase activity. Thoserequired for this activity. Activation of NMDA receptors
clones that both grew on triple-deficient plates and turned blue indramatically induced the redistribution of both GRASP-1
the b-galactosidase assay were selected, and their plasmids were
and AMPA receptors from punctate membrane struc- isolated and transformed into E. coli DH10B. The E. coli clones
tures to a more diffuse pattern. Together with the containing the pPC86 construct were rescued and their plasmids
GRASP-1 overexpression data, these results suggest were isolated. The positive clones were cotransformed into yeast
that the overall spatial distribution of GRASP-1, as well Y190 with either the bait vector or the original pPC97 vector to
as the absolute levels, may be important for AMPA re- confirm the interaction.
To obtain the full-length cDNA of GRASP-1, the SalI/SacI fragmentceptor targeting. These results suggest that GRASP-1
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(about 300 bp) of yeast clone D7-D-12 (1.4 kb) was used as a probe mCi/ml (NEN), 1 ml of 40 mg/ml Rnasin ribonuclease inhibitor (Pro-
mega, WI), and 1 mg of GRASP-1 cDNA subcloned in vectorto screen rat hippocampal cDNA libraries. Both a CapFinder library
and an oligo-dT-primed library subcloned in phage l ZAP were used pCDNA3.1(2) were mixed in a volume of 50 ml at 308C for 1 hr.
To perform the caspase-3 cleavage reaction in vitro, 1 ml of in(both are gifts of Dr. Anthony Lanahan and Dr. Paul Worley). The
CapFinder library was constructed with the CapFinder PCR cDNA vitro±translated protein sample or 2 mg of brain lysate was incubated
with 1 ml of purified active recombinant human caspase-3 (Phar-library Construction Kit (Clontech Laboratories, CA). This library
construction method takes advantage of the 7-methylguanosine cap mingen) in 18 ml caspase cleavage reaction buffer (20 mM PIPES,
100 mM NaCl, 10 mM DTT, 1 mM EDTA, 0.1% CHAPS, and 10%structure, which is present on the 59 end of all eukaryotic mRNAs
to enrich the full-length clones in the resulting library. sucrose [pH 7.2]) at 378C for 2 hr.
To generate caspase cleavage-deficient mutants, amino acids
D591 and D594 were point mutated to glutamates with the Quik-Antibody Generation and Purification and Western Analysis
Change Site-Directed Mutagenesis kit (Stratagene, CA).The cDNA encoding the last 156 amino acids of GRASP-1 was
subcloned into vector pTrcHisB (Invitrogen, CA) in a fusion with an
N-terminal polyhistidine (His6) tag and transformed into E. coli BL21.
GDP Dissociation AssayThe His6-tagged fusion protein was purified in denaturing condition
To load ras with [3H]GDP (NEN), 0.5 mg GST-ras (Upstate Biotechnol-according to the procedure provided by the manufacturer of the
ogy) was incubated with 10 mCi [3H]GDP in 50 ml nucleotide loadingpTrcHis protein purification system (Invitrogen, CA). To generate a
buffer (50 mM Tris with 10 mM EDTA, 5 mM MgCl2, 1 mM DTT, andpeptide antigen, a peptide containing the last 20 amino acids of
1 mg/ml BSA) at 378C. Twenty minutes later 60 ml of nucleotideGRASP-1 was synthesized (RH157) and cross-linked to thyroglobu-
loading stopping buffer (50 mM Tris-HCl [pH 7.4] with 5 mM MgCl2,lin. The fusion protein and the peptide were then used to immunize
1 mM DTT, and 1 mg/ml BSA) was added. The 110 ml sample wastwo New Zealand White rabbits (JH 2377 and JH 2730, respectively)
divided in two, and each sample was added to 500 ml dissociation(Hazleton Research Products).
reaction buffer (25 mM Tris-HCl [pH 7.4] with 2 mM MgCl2, 1 mMVarious organs and different regions of the nervous systems of
DTT, 1 mg/ml BSA, and 0.1 mM GDP) containing 1 mg GST-GRASP-Sprague-Dawley rats were homogenized and sonicated. The ho-
1-C and 1 mg GST, respectively. The two reactions were incubatedmogenates were centrifuged at 1000 3 g for 15 min. The supernatant
at 378C. A sample (100 ml) was then removed from each mixture at(10 mg) from each tissue was lysed in Laemmli buffer (Laemmli,
specific time points and mixed with 200 ml ice-cold dissociation1970) and loaded onto 7.5% SDS±PAGE gels and transferred to
reaction stopping buffer (50 mM Tris-HCl [pH 7.4] with 10 mM MgCl2).PVDF membranes. Anti-GP1-PDZ antibody (JH2377, 1:5000) or anti-
Filtration was performed on HA filters (Millipore, 0.45 mm), and theGP1-C (JH2730, 1:5000) was used as the primary antibody for West-
radioactivity was measured by liquid scintillation counting.ern analysis.
Immunohistochemistry Coimmunoprecipitation
Male Sprague-Dawley rats (200±350 g) were anesthetized with pen- For coimmunoprecipitation in heterologous cells, quail fibroblast
tobarbital (50 mg/kg) and perfused transcardially with 100 ml of QT-6 cells were transfected with no DNA, full-length GRIP1 alone,
cold 0.1 M phosphate-buffered saline (PBS), followed by cold 4% Myc-tagged GRASP-1 clone D7-4 (C-terminal 1.2 kb) subcloned in
paraformadehyde/0.1 M phosphate buffer (pH 7.3). Brains were re- vector pRK5, or full-length GRIP1 and Myc-tagged D7-4 together.
moved and postfixed for 2 hr at 48C and cryoprotected in 30% Two days later, the cells were lysed in immunoprecipitation buffer
sucrose/PBS overnight at 48C. Coronal and sagittal sections (40 mm) (IPB: 13 PBS with 100 mM phenylmethylsulfonylfluoride [PMSF] and
were made with a sliding microtome and washed with PBS followed 20 mg/ml aprotinin) containing 1% Triton X-100. The soluble fraction
by incubation in 0.6% H2O2 /10% ethanol/PBS for 15 min at room was incubated with either anti-GRIP1 antibody (JH2260, purified) or
temperature. After being blocked and permeabilized in 10% normal anti-Myc antibody (monoclonal) and protein A-Sepharose (1:1 slurry)
goat serum/2% skim milk/0.2% Triton X-100/PBS for 1 hr at room for 2 hr at 48C. The mixture was then washed once with IPB con-
temperature, the sections were incubated with GP1-PDZ antiserum taining 1% Triton X-100, twice with IPB containing 1% Triton X-100
(JH2377) at a dilution of 1:10,000 in 2% normal goat serum/2% skim and 500 mM NaCl, and three times with IPB. The proteins were
milk/PBS overnight at 48C. Preimmune serum at the same dilution eluted with Laemmli sample buffer (Laemmli, 1970), and loaded onto
was used as negative control. The sections were then washed in 12% SDS-polyacrylamide gels. Western analysis was performed
PBS, incubated with 1:300 biotinylated goat anti-rabbit antibody in with either anti-Myc antibody, if anti-GRIP1 antibody was used for
PBS for 1 hr at room temperature, and subsequently incubated immunoprecipitation, or with anti-GRIP1, if anti-Myc antibody was
with avidin-biotin-peroxidase complex for 1 hr at room temperature used for immunoprecipitation.
(Vector Labs, CA). After incubation with 55% 3,3-diaminobenzidine For coimmunoprecipitation of the endogenous proteins from cul-
tetrahydrochloride (DAB)/0.1% H2O2/50 mM Tris-HCl for 5±15 min, tured neurons, cortical cultured neurons (embryonic day 17, 2±3
the sections were dehydrated and mounted. weeks in vitro) were solubilized with 2% Triton X-100 in IPB (13
PBS with 100 mM phenylmethylsulfonylfluoride [PMSF] and 20 mg/
Subcellular Fractionation ml aprotinin). Soluble fraction after centrifugation at 14,000 3 g for
Subcellular fractionation was performed according to Carlin et al. 10 min was used as input for immunoprecipitation. 1 mg of either
(1980) with the following modifications. The synaptosomal fraction anti-GRIP1 (C8399, gift of Dr. M. Sheng), anti-Myc, or anti-SAP102
was solubilized in 0.5% ice-cold Triton X-100 for 15 min and centri- was added to the input lysates together with 50 ml of protein
fuged at 32,000 3 g for 20 min to obtain the PSD1 fraction. PSD1 A-Sepharose (1:1 slurry) and incubated for 3 hr at 48C. The mixture
was resuspended and solubilized either in 0.5% Triton X-100 or in was then washed in the same way as the coimmunoprecipitation in
3% sarcosyl (ice cold) for 10 min and then centrifuged at 200,000 3 heterologous cells and eluted with 50 ml Laemmli sample buffer.
g for 1 hr to obtain the PSD2 or PSD3 fractions, respectively. After Twenty microliters of the elute were loaded onto 7.5% SDS-poly-
the fractions were resuspended in 40 mM Tris-HCl (pH 8.0), the acrylamide gels and Western analysis was performed with anti-
protein concentrations were determined by BCA assay (Pierce GRASP-1 antibody (anti-GP1-Pep, 1:5000).
Chemical, IL). Equal amounts of proteins were then solubilized in For coimmunoprecipitation of the endogenous proteins from rat
Laemmli buffer and separated by SDS±PAGE. brain, the total membrane fraction (P2) was prepared from rat brain
cortex homogenate and solubilized with sodium deoxycholate
(Fisher Scientific, NJ) according to Luo et al. (1997). The solubilizedIn Vitro Caspase-3 Cleavage Assay, In Vitro Translation,
and Generation of the Cleavage-Deficient Mutant P2 fraction (200±500 mg) was incubated with 25 ml of protein
A-Sepharose (bed volume) and monoclonal antibodies againstCoupled in vitro transcription and translation was performed with
the TNT Coupled Reticulocyte Lysate System (Promega, WI). In GluR2 (Chemicon), NR1 (S3C11), or Myc (9E10) at 48C for 2 hr. The
immunoprecipitate was then washed three times with binding bufferbrief, 25 ml of TNT rabbit reticulocyte lysate, 2 ml of TNT reaction
buffer, 1 ml of TNT T7 RNA polymerase, 1 ml of 1 mM amino acid and eluted with 50 ml of 23 Laemmli sample buffer and boiled for
5 min before loading onto SDS-polyacrylamide gels.mixture minus methionine, [35S]methionine (1,000 Ci/mmol) at 10
GRASP-1: A GRIP-Associated Neuronal RasGEF
615
Neuron Cultures, Immunocytochemistry, Transfection, Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E.,
Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F., et al. (1996).and Drug Treatment
Low-density hippocampal neurons were cultured following the pro- Interaction of nitric oxide synthase with the postsynaptic density
protein PSD-95 and a1-syntrophin mediated by PDZ domains. Cellcedure described by Goslin and Banker (1991). For immunocyto-
chemistry, cultured neurons growing on coverslips (3 weeks in vitro) 84, 757±767.
were sequentially fixed in 4% paraformaldehyde/4% sucrose for 30 Bruckner, K., Pablo Labrador, J., Scheiffele, P., Herb, A., Seeburg,
min and cold methanol (2208C) for 20 min and then were permeabil- P.H., and Klein, R. (1999). EphrinB ligands recruit GRIP family PDZ
ized in 0.2% Triton X-100 for 20 min at 48C. After washing three adaptor proteins into raft membrane microdomains. Neuron 22,
times in 13 PBS, the neurons were first incubated with 10% normal 511±524.
donkey serum and then incubated with fluorescent dye-labeled anti-
Buday, L., and Downward, J. (1993). Epidermal growth factor regu-bodies at 378C for 2 hr. After washing in 13 PBS three times, the
lates p21ras through the formation of a complex of receptor, Grb2coverslips were mounted onto glass slides with PermaFluor Aqueour
adapter protein, and Sos nucleotide exchange factor. Cell 73,(Lipshaw Immunon, Pittsburgh, PA) containing 0.25% 1,4-diazabi-
611±620.cyclo-[2.2.2]-octane (DABCO) (Aldrich Chemical, WI).
Carlin, R.K., Grab, D.J., Cohen, R.S., and Siekevitz, P. (1980). Isola-For transfection studies, low-density hippocampal neurons were
tion and characterization of postsynaptic densities from varioustransfected at 3±5 days in vitro with pEGFP-C1, which was an empty
brain regions: enrichment of different types of postsynaptic densi-vector encoding green fluorescent protein (Clontech Laboratories,
ties. J. Cell Biol. 86, 831±845.CA), Myc-GRASP-1, or mutants subcloned in mammalian expres-
sion vector pRK5. The transfections were carried out by the calcium Carroll, R.C., Lissin, D.V., von Zastrow, M., Nicoll, R.A., and Malenka,
phosphate method (Xia et al., 1996; Threadgill et al., 1997). The R.C. (1999). Rapid redistribution of glutamate receptors contributes
neurons were then stained at about 2 weeks after the transfection to long-term depression in hippocampal cultures. Nat. Neurosci. 2,
with the method described above. 454±460.
Cortical neurons from embryonic day 17 Sprague-Dawley rats Chan, S.L., and Mattson, M.P. (1999). Caspase and calpain sub-
were cultured according to the procedure of Ghosh and Greenberg strates: roles in synaptic plasticity and cell death. J. Neurosci. Res.
(1995), except that the cells were maintained in minimum essential 58, 167±190.
medium (MEM) supplemented with 5% heat-inactivated horse se-
Chardin, P., Camonis, J.H., Gale, N.W., van Aelst, L., Schlessinger,rum. For glutamate treatment, cortical neurons were incubated in
J., Wigler, M.H., and Bar-Sagi, D. (1993). Human Sos1: a guaninenormal media containing 40 mM glutamate for 5 min and were then
nucleotide exchange factor for Ras that binds to GRB2. Scienceimmediately fixed. For blocking by glutamate receptor antagonist,
260, 1338±1343.200 mM APV or 20 mM CNQX was added together with 40 mM
Chen, H.J., Rojas-Soto, M., Oguni, A., and Kennedy, M.B. (1998). Aglutamate for 5 min.
synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by
CaM kinase II. Neuron 20, 895±904.Acknowledgments
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